Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the opening of a new affiliate storefront, The Healing Research Center in Pittsburgh. As part of the state’s Chapter 20 Clinical Registrant Program, the dispensary will, in collaboration with the Drexel University Medical Cannabis Research Center, conduct ongoing research on medical cannabis and its effects on various conditions covered by the program in Pennsylvania. The Healing Research Center in Pittsburgh is Western Pennsylvania’s first medical cannabis dispensary to feature a drive-through platform for its patients and is located near Interstate exits from both I-79 and I-376 at Robinson Centre Drive, which typically see combined traffic of approximately 200,000 cars per day, according to the Pennsylvania Department of Transportation.
“With this flagship dispensary and the unique partnership with Drexel, we have the opportunity to help enhance the medical cannabis program in Pennsylvania, a core market for Verano and one of the largest in the country,” said George Archos, Verano Founder and CEO. “Research supports our vision of driving continuous improvement in patient care and experience. This initiative brings together some of the brightest talent in our industry with one of the finest medical institutions in Pennsylvania, working collectively to optimize the medical cannabis landscape for generations of patients to come.”
Verano affiliate Agronomed Biologics is permitted to open a medical cannabis cultivation and production facility as well as six dispensaries in Pennsylvania through its Clinical Registrant permit. The Healing Research Center is located at 6300 Robinson Centre Drive in Pittsburgh. The dispensary is set to open on Friday, July 30th at 10:00 a.m. local time. Regular business hours will be Monday through Friday 10:00 a.m. to 8:00 p.m., Saturday 10:00 a.m. to 6:00 p.m., and Sunday 10:00 a.m. to 4:00 p.m.
Verano is a leading, vertically-integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products. With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano™, Avexia™, Encore™, and MÜV™. Verano’s portfolio encompasses 14 U.S. states, with active operations in 11, including 10 production facilities comprising approximately 832,000 square feet of cultivation (including a 26,000 sq. ft. facility in Massachusetts nearing completion of construction). Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf™ and MÜV™, delivering a superior cannabis shopping experience in both medical and adult-use markets. Learn more at www.verano.com.